Does Aetna (CVS Health) Cover Finasteride?
A detailed breakdown of Aetna's finasteride coverage policies, formulary tiers, prior authorization criteria, step therapy requirements, and how to appeal a denial, with real dose and cost figures.
85 source-based articles maintained by the HealthRX.com Editorial Team.

Showing 85 of 85 clinical reviews.
A detailed breakdown of Aetna's finasteride coverage policies, formulary tiers, prior authorization criteria, step therapy requirements, and how to appeal a denial, with real dose and cost figures.
A clinical and insurance guide to Anthem (Elevance Health) finasteride coverage, prior authorization criteria, step therapy requirements, formulary tier placement, and how to appeal a denial.
A clinical and insurance guide to Blue Cross Blue Shield (Federated) coverage of finasteride for male pattern hair loss and BPH, including formulary tiers, prior authorization criteria, step therapy, appeals, and cash-pay alternatives.
A detailed guide to Cigna's finasteride coverage for hair loss and BPH: formulary tier, prior authorization requirements, step therapy, appeal strategies, and cost-saving options.
A detailed guide to Humana finasteride coverage across commercial and Medicare Advantage plans, including formulary tiers, prior authorization steps, step therapy rules, and how to appeal a denial.
A clinical guide to Kaiser Permanente's formulary status, prior authorization criteria, step therapy requirements, and appeal pathway for finasteride (1 mg and 5 mg) for hair loss and BPH.
A state-by-state guide to Medicaid coverage of finasteride for male pattern hair loss and BPH, including prior authorization criteria, step therapy requirements, appeal strategies, and cash-pay alternatives.
Find out whether TRICARE covers finasteride for hair loss or BPH, what prior authorization looks like, which formulary tier it sits on, and how to appeal a denial step by step.
A guide to UnitedHealthcare finasteride coverage, formulary tier, prior authorization criteria, step therapy requirements, and how to appeal a denial.
Finasteride is not FDA-approved for adolescents aged 12, 17. This guide covers off-label dosing considerations, pubertal safety concerns, mental health monitoring, and evidence-based alternatives for early-onset androgenetic alopecia.
Complete finasteride dosing guide for adults aged 30 to 49, covering 1 mg for hair loss and 5 mg for BPH, with trial data, safety monitoring, and clinical considerations.
Complete 2026 guide to finasteride pricing in Arizona: cash-pay rates as low as $12/month, GoodRx coupons, Arizona Medicaid rules, 503A compounded finasteride legality, and telehealth access.
How much does finasteride cost in Colorado in 2026? Retail cash prices, compounded options, Medicaid coverage, insurance tiers, and discount programs explained with clinical context.
How much does finasteride cost in Connecticut in 2026? Cash prices, Medicaid coverage, compounded options, insurance rules, and discount strategies explained with clinical context.
A complete breakdown of finasteride pricing in Florida for 2026, covering cash-pay generics, telehealth, Medicaid coverage, compounded 503A pharmacies, and discount programs.
Complete 2026 guide to finasteride cost in Georgia. Compare cash-pay prices ($12/month), compounded finasteride ($45/month), Medicaid coverage rules, insurance tiers, and telehealth access for Georgia residents.
Complete guide to finasteride pricing in Illinois for 2026. Covers generic cash-pay costs, Illinois Medicaid coverage with prior authorization, compounded finasteride from 503A pharmacies, insurance plans, and telehealth access.
Find out exactly what finasteride costs in Iowa in 2026, which insurance plans and Medicaid programs cover it, whether compounded finasteride is legal, and how to pay as little as $12 per month.
How much does finasteride cost in Massachusetts in 2026? Cash prices, Medicaid coverage, compounded finasteride legality, insurance rules, and the cheapest ways to fill your prescription in MA.
How much finasteride costs in Nevada in 2026, including cash-pay prices, compounded options, Medicaid coverage, insurance rules, and the cheapest ways to fill your prescription.
A complete 2026 guide to finasteride pricing in New York, covering generic cash-pay costs, Medicaid coverage with prior authorization, 503A compounded finasteride legality, telehealth access, and every savings strategy available to NY residents.
How much does finasteride cost in Oregon in 2026? Compare cash-pay, generic, compounded, Medicaid, and insurance prices with guidance.
Finasteride costs as little as $12/month cash-pay at Utah pharmacies in 2026. Learn exact prices, whether Utah Medicaid covers it, compounded finasteride legality, telehealth access, and the fastest ways to lower your out-of-pocket cost.
Complete 2026 guide to finasteride pricing in Virginia. Covers cash-pay retail costs, Virginia Medicaid PA rules, compounded finasteride 503A legality, insurance coverage, and telehealth access.
How much does finasteride cost in West Virginia in 2026? Cash prices, Medicaid coverage, compounded options, telehealth access, and discount programs explained with real numbers.
How does finasteride cost compare to dutasteride, minoxidil, and other hair-loss and BPH treatments? A breakdown of mechanism, pricing, efficacy, and when to switch.
Evidence-based finasteride dosing for adults ages 50 to 64, covering AGA (1 mg) and BPH (5 mg) indications, polypharmacy interactions, cardiovascular considerations, and monitoring protocols.
A guide to finasteride dosing for men aged 18, 29, covering 1 mg AGA and 5 mg BPH protocols, fertility considerations, sexual side-effect data, and monitoring recommendations.
Evidence-based guide to finasteride use in patients with liver disease, including pharmacokinetic considerations, dose adjustments, and monitoring recommendations for prescribers.
Finasteride requires no dose adjustment in renal impairment. This MD-reviewed guide covers the pharmacokinetic data, hepatic metabolism, and clinical considerations for prescribing finasteride to patients with kidney disease.
Finasteride evolution traces 25+ years from oral 1mg to new topical and nanoparticle formulas cutting systemic absorption up to 95% while maintaining DHT reduction.
Finasteride works with or without food; meals don't change absorption. Avoid saw palmetto and St. John's Wort, and stop biotin 72 hours before lab tests.
Evidence-based guide to finasteride dosing in adults 65 and older, covering BPH and hair loss indications, renal considerations, drug interactions, and deprescribing.
Evidence-based monitoring guide for finasteride use in adults 65 and older, covering PSA adjustments, renal function, sexual side effects, falls risk, and deprescribing timelines.
Finasteride's terminal half-life is 5 to 6 hours in men 18-60 (8+ hours over 70), but its effect on DHT lasts much longer due to irreversible enzyme binding.
A detailed timeline of finasteride's discovery, FDA approvals, mechanism of action, and clinical development from Merck's 5-alpha reductase research through modern generic availability.
Evidence-based guide to finasteride use in transplant recipients, people living with HIV, patients with liver disease, and other special populations. Covers drug interactions, dose adjustments, and monitoring.
A clinician-level review of how finasteride is made, which manufacturers supply it, what caused past shortages, and what patients and prescribers should know about supply risks today.
A physician-level explanation of how finasteride inhibits 5-alpha reductase type II, reduces scalp DHT, and reverses miniaturization in androgenetic alopecia and BPH.
Missed a finasteride dose? Don't double up. Take it the same day if you remember; if your next dose is close, skip it and resume your regular schedule.
A clinical guide to monitoring finasteride in adults aged 30 to 49, covering baseline labs, PSA adjustments, hormonal panels, sexual function screening, and follow-up schedules for both AGA and BPH indications.
A clinical guide to monitoring finasteride in adults aged 50 to 64, covering PSA correction, baseline labs, sexual side-effect tracking, polypharmacy review, and evidence-based timelines.
A complete clinical reference for monitoring finasteride use in adolescents aged 12 to 17, covering growth, hormonal, psychiatric, and sexual health parameters with evidence-based thresholds and timelines.
Evidence-based finasteride monitoring schedule covering baseline labs, PSA adjustments, liver function, hormones, and follow-up exams for men on 1 mg or 5 mg finasteride.
A guide to finasteride's off-label applications beyond BPH and male pattern hair loss, with trial data and evidence grading for each use.
A guide to finasteride overdose, accidental excess dosing, mechanism of action, and 5-alpha reductase inhibition, with FDA-cited evidence and toxicology data.
A comprehensive guide to finasteride's mechanism of action, patent expiration, generic availability, and clinical evidence for AGA and BPH.
Finasteride has no FDA-approved pediatric dosing for children under 12. Learn why this 5-alpha reductase inhibitor is contraindicated in prepubertal patients, what the evidence says, and when rare exceptions may apply.
Evidence-based guide to monitoring finasteride use in pediatric patients under 12, including lab schedules, growth tracking, hormonal surveillance, and safety protocols for off-label prescribing.
A comprehensive clinical review of finasteride safety in children under 12, covering FDA labeling, hormonal risks, contraindications, and the rare pediatric conditions where off-label use has been studied.
How SRD5A1/SRD5A2 polymorphisms, CYP3A4 variants, and androgen-receptor genetics shape finasteride response, adverse-effect risk, and dosing decisions, with PubMed-cited evidence.
Finasteride is contraindicated in women who are or may be pregnant: the drug blocks 5-alpha reductase type II, which is required for normal male genital development in a fetus.
A clinician-grade review of finasteride real-world evidence from patient registries, electronic health record studies, and post-marketing surveillance for hair loss and BPH.
A clinician-grade overview of finasteride's regulatory approvals across the US, EU, Canada, and UK, including approved indications, dose forms, generic availability, and post-market safety actions.
A clinical review of finasteride safety data for men aged 30 to 49, covering sexual side effects, mental health signals, post-finasteride syndrome, liver and cardiovascular markers, and monitoring protocols.
A guide to finasteride safety in adults aged 50, 64, covering cardiovascular risk, drug interactions, sexual side effects, prostate cancer screening, and dosing for AGA and BPH.
A clinical review of finasteride safety data, off-label use considerations, growth and hormonal risks, and monitoring requirements for adolescents ages 12 to 17 with male-pattern hair loss.
Evidence-based review of finasteride safety in geriatric patients (65+), covering sexual side effects, PSA masking, cognitive concerns, falls risk, polypharmacy, and when to consider stopping.
Finasteride at 18 is FDA-approved at 1 mg daily for male pattern hair loss; sexual side effects hit 3.8% vs 2.1% on placebo and most resolve on stopping.
Finasteride side effects: trials showed sexual problems in 3.8% of users vs 2.1% on placebo. FDA labels now add warnings for depression and suicidality.
Showing the first 60 matches. Use search or filters to narrow the library.